TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 1 | 6 | 8 | -17 | -23 | -26 | -9 |
| P | %wins | 100 | 100 | 100 | 33 | 33 | 0 | 61 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/30/23 16:58 | 3/10/23 | MIRO | Miromatrix Medical Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Maag Peter | MN | D | P | 50 | 1.60 | 0 | 31 | 89 | 66 | D | |||||||||||||||
8/16/17 18:22 | 8/15/17 | CDNA | Caredx, Inc. | DE | Health | Health | Medical Laboratories | Maag Peter | CA | DO | See Rema | P | 1 | 1.82 | 0 | 1 | 1 | 110 | D | ||||||||||||||
10/4/16 16:58 | 9/26/16 | CDNA | Caredx, Inc. | DE | Health | Health | Medical Laboratories | Maag Peter | CA | DO | P,CEO | P | 40 | 4.00 | 0 | 10 | 13 | 89 | D | -47 | -15 | -28 | -21 | -19 | -14 | -2 | 0 | 2 | 10 | 3 | -34 | -59 | |
6/3/15 17:36 | 6/1/15 | CDNA | Caredx, Inc. | DE | Health | Health | Medical Laboratories | Maag Peter | CA | DO | P,CEO | P | 10 | 4.84 | 0 | 2 | 4 | 52 | D | -28 | -21 | 0 | 4 | 7 | 10 | 0 | 7 | 18 | 27 | 19 | -22 | ||
7/23/14 20:39 | 7/22/14 | CDNA | Caredx, Inc. | DE | Health | Health | Medical Laboratories | Maag Peter | CA | DO | See Rema | P | 250 | 10.00 | 4 | 25 | 24 | M | 10 | 0 | 0 | 2 | -44 | -29 | -29 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |